KATIE WHITE: Open Payments
NPI 1871041350 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,789 in 103 payments from 18 companies in 2025. Trend: 2023 $1,483 · 2024 $1,593 · 2025 $1,789
Food & beverage: $1,789
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $591 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $324 |
| Regeneron Healthcare Solutions, Inc. | 8 | $212 |
| GENZYME CORPORATION | 6 | $154 |
| Stryker Corporation | 4 | $117 |
| Janssen Biotech, Inc. | 3 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Phathom Pharmaceuticals, Inc. | 4 | $57 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| Optinose US, Inc. | 1 | $23 |
Products named: DUPIXENT, RINVOQ, ENTYVIO, SKYRIZI, XPRESS LOPROFILE, MAVYRET, TREMFYA, XIFAXAN.
Industry payments across AL — which companies pay providers there.
